A) Preoperative breast MRI, initial DCE post-contrast axial fat-saturated T1...
A) Preoperative breast MRI, initial DCE post-contrast axial fat-saturated T1 axial subtraction image, demonstrates 6 cm clumped enhancement surrounding biopsy clip (arrow). B) Ultrafast imaging, post-contrast subtraction with TTE of 5 seconds (arrow)

Image credit: ARRS/AJR

News • Predicting DCIS upgrade

Breast cancer: ultrafast MRI shows promise

Ultrafast MRI provides beneficial information that can be used in surgical planning, including determining the need to perform sentinel lymph node biopsy.

This is according to an accepted manuscript published in ARRS’ American Journal of Roentgenology (AJR). “Preoperative UF-MRI, time to enhancement, and lesion size on conventional dynamic contrast-enhanced (DCE) MRI and mammography show potential in predicting upgrade of ductal carcinoma in situ (DCIS) to invasive cancer at surgery,” wrote first author Rachel Miceli, MD, of NYU Langone Health.

The manuscript identified consecutive women with biopsy-proven pure DCIS lesions who underwent UF-MRI with DCE-MRI and had subsequent surgery between August 2019 and January 2021. To determine predictors of upgrade to invasive cancer, patient and lesion characteristics; biopsy method and pathology; as well as lesion features on mammography, ultrasound, DCE-MRI, and UF-MRI were assessed. 

Ultimately, at surgery, 38% of lesions diagnosed as DCIS at percutaneous biopsy were upgraded to invasive cancer. Time to enhancement on UF-MRI was associated with upgrade from DCIS to invasive cancer (p=.03) with an optimal threshold of 11 seconds (specificity, 50%; sensitivity, 76%). 

Reiterating that short time to enhancement can assist prediction of lesions diagnosed as DCIS at percutaneous biopsy that will be upgraded to invasive cancer at surgery, “further studies with larger cohorts will be helpful in assessing the contribution of UF-MRI for the prediction of upgrade in clinical practice,” Miceli et al. concluded. 


Source: American Roentgen Ray Society

09.02.2023

Read all latest stories

Related articles

Photo

News • Surgical navigation system

Breast cancer localization: study puts new device to the test

A new device that acts like a GPS to locate and remove breast and lymph node tumors was tested for its safety and effectiveness in a feasibility study - with promising results.

Photo

News • BPE in dense breasts

Breast cancer: elevated MRI enhancement identifies higher risk

A machine learning model found that background parenchymal enhancement (BPE) on breast MRI is an indicator of breast cancer risk in women with extremely dense breasts.

Photo

News • Imaging study shows

Breast MRI effective at detecting cancer in dense breasts

Compared to other common supplemental screening methods, breast MRI was superior at detecting breast cancer in women with dense breasts, according to a new study.

Related products

32 Inch Height-Adjustable MRI LED Screen

Accessories / Complementary Systems

allMRI · 32 Inch Height-Adjustable MRI LED Screen

allMRI GmbH
50° wide-angle Tomosynthesis

Tomosynthesis

Siemens Healthineers · 50° wide-angle Tomosynthesis

Siemens Healthineers AG
Accutron MR

Injectors

Medtron AG · Accutron MR

MEDTRON AG
Accutron MR3

Injectors

Medtron AG · Accutron MR3

MEDTRON AG
Advanced Breast-CT - nu:view

Mammo CT

AB-CT · Advanced Breast-CT - nu:view

AB-CT – Advanced Breast-CT GmbH
Advanced intelligent Clear-IQ Engine for MR

Artificial Intelligence

Canon · Advanced intelligent Clear-IQ Engine for MR

Canon Medical Systems Europe B.V.
Subscribe to Newsletter